| The role of PI3K/Akt and ERK in neurodegenerative disorders SN Rai, H Dilnashin, H Birla, SS Singh, W Zahra, AS Rathore, BK Singh, ... Neurotoxicity research 35, 775-795, 2019 | 371 | 2019 |
| Inhibition of amyloid fibril growth and dissolution of amyloid fibrils by curcumin–gold nanoparticles S Palmal, AR Maity, BK Singh, S Basu, NR Jana, NR Jana Chemistry–A European Journal 20 (20), 6184-6191, 2014 | 167 | 2014 |
| Poly (trehalose) nanoparticles prevent amyloid aggregation and suppress polyglutamine aggregation in a Huntington’s disease model mouse K Debnath, N Pradhan, BK Singh, NR Jana, NR Jana ACS Applied Materials & Interfaces 9 (28), 24126-24139, 2017 | 131 | 2017 |
| Mitochondrial dysfunction: a potential therapeutic target to treat Alzheimer’s disease SN Rai, C Singh, A Singh, MP Singh, BK Singh Molecular Neurobiology 57 (7), 3075-3088, 2020 | 106 | 2020 |
| Mucuna pruriens in Parkinson’s and in some other diseases: recent advancement and future prospective SN Rai, VK Chaturvedi, P Singh, BK Singh, MP Singh 3 Biotech 10, 1-11, 2020 | 92 | 2020 |
| Promising drug targets and associated therapeutic interventions in Parkinson’s disease SN Rai, P Singh, R Varshney, VK Chaturvedi, E Vamanu, MP Singh, ... Neural regeneration research 16 (9), 1730-1739, 2021 | 90 | 2021 |
| Azadiradione restores protein quality control and ameliorates the disease pathogenesis in a mouse model of Huntington’s disease BK Singh, N Vatsa, VK Nelson, V Kumar, SS Kumar, SC Mandal, M Pal, ... Molecular neurobiology 55, 6337-6346, 2018 | 32 | 2018 |
| Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome I Jamal, V Kumar, N Vatsa, S Shekhar, BK Singh, A Sharma, NR Jana Neurobiology of Disease 105, 99-108, 2017 | 28 | 2017 |
| Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer’s disease BK Singh, N Vatsa, V Kumar, S Shekhar, A Sharma, NR Jana Human Molecular Genetics 26 (20), 4042-4054, 2017 | 27 | 2017 |
| Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology M Maheshwari, S Shekhar, BK Singh, I Jamal, N Vatsa, V Kumar, ... Human molecular genetics 23 (23), 6235-6245, 2014 | 26 | 2014 |
| Quality control in Huntington’s disease: A therapeutic target SN Rai, BK Singh, AS Rathore, W Zahra, C Keswani, H Birla, SS Singh, ... Neurotoxicity Research 36, 612-626, 2019 | 24 | 2019 |
| Down-regulation of miRNA-708 promotes aberrant calcium signaling by targeting neuronatin in a mouse model of angelman syndrome N Vatsa, V Kumar, BK Singh, SS Kumar, A Sharma, NR Jana Frontiers in Molecular Neuroscience 12, 35, 2019 | 22 | 2019 |
| A nexus of miR-1271, PAX4 and ALK/RYK influences the cytoskeletal architectures in Alzheimer's Disease and Type 2 Diabetes P Majumder, K Chanda, D Das, BK Singh, P Chakrabarti, NR Jana, ... Biochemical Journal 478 (17), 3297-3317, 2021 | 20 | 2021 |
| Cellular levels of Grb2 and cytoskeleton stability are correlated in a neurodegenerative scenario P Majumder, K Roy, BK Singh, NR Jana, D Mukhopadhyay Disease Models & Mechanisms 10 (5), 655-669, 2017 | 19 | 2017 |
| Commentary: Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42: Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the … SN Rai, VK Chaturvedi, BK Singh, MP Singh Frontiers in Aging Neuroscience 12, 219, 2020 | 15 | 2020 |
| Environmental enrichment improves behavioral abnormalities in a mouse model of Angelman syndrome I Jamal, V Kumar, N Vatsa, BK Singh, S Shekhar, A Sharma, NR Jana Molecular neurobiology 54, 5319-5326, 2017 | 15 | 2017 |
| Simvastatin restores HDAC1/2 activity and improves behavioral deficits in Angelman syndrome model mouse V Kumar, T Joshi, N Vatsa, BK Singh, NR Jana Frontiers in Molecular Neuroscience 12, 289, 2019 | 14 | 2019 |
| Transcriptomic analysis of human ALS skeletal muscle reveals a disease-specific pattern of dysregulated circRNAs D Tsitsipatis, K Mazan-Mamczarz, Y Si, AB Herman, JH Yang, A Guha, ... Aging (Albany NY) 14 (24), 9832, 2022 | 13 | 2022 |
| Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington’s disease S Shekhar, N Vatsa, V Kumar, BK Singh, I Jamal, A Sharma, NR Jana Human molecular genetics 26 (2), 420-429, 2017 | 9 | 2017 |
| Inhibition of Ephrin B2 Reverse Signaling Abolishes Multiple Myeloma Pathogenesis JP Sasine, NY Kozlova, L Valicente, J Dukov, DH Tran, HA Himburg, ... Cancer research 84 (6), 919-934, 2024 | 1 | 2024 |
Nihar JanaDepartment of Bioscience and Biotechnology, Indian Institute of Technology, KharagpurVerified email at iitkgp.ac.in
